stockrowLantheus Holdings, Inc. (LNTH) vs Indivior Pharmaceuticals Inc. (SUPN)
- Lantheus Holdings, Inc. LNTH 100.76 −0.38%
- Indivior Pharmaceuticals Inc. SUPN 28.21 +0.21%
Lantheus Holdings, Inc. and Indivior Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. Lantheus Holdings, Inc. is the larger, with a market value of $6.6B against $5.6B — 1.2× the size. Indivior Pharmaceuticals Inc. trades at the lower P/E: 7.6× against 24.3×. Indivior Pharmaceuticals Inc. grew revenue faster over the last twelve months: 16.4% against 2.38%. Indivior Pharmaceuticals Inc. has the higher net margin (32.9% vs 17.3%) and the higher return on invested capital (283.0% vs 14.6%). Across the 20 metrics below, Indivior Pharmaceuticals Inc. leads on 14 and Lantheus Holdings, Inc. on 6.
Valuation
Profitability
| Metric | LNTH | SUPN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 61.26% | 84.85% | 53.51% |
| Operating margin | 18.62% | 40.57% | 0.00% |
| Net margin | 17.28% | 32.85% | (2.45%) |
| Free cash flow margin | 26.21% | 2.26% | 0.00% |
| Return on equity | 21.81% | (337.83%) | (0.80%) |
| Return on assets | 11.41% | 32.82% | (1.67%) |
| Return on invested capital | 14.62% | 283.03% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack